Incidence and diagnosis of active toxoplasma infection among liver transplant recipients in Western Turkey
Open Access
- 29 September 2008
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Liver Transplantation
- Vol. 14 (10), 1526-1532
- https://doi.org/10.1002/lt.21558
Abstract
Toxoplasmosis is a serious and potentially life‐threatening disease in liver transplant recipients while they are immunosuppressed. We report the clinical and laboratory findings related to active toxoplasma infection associated with 40 immunosuppressed liver transplant procedures that took place over a 12‐month period at a major transplant unit in Izmir, Turkey. Twenty‐seven (67.5%) of the 40 transplant recipients were found to be seropositive for toxoplasma infection and therefore at risk of reactivated infection. From the serological status of the donors, which was ascertained in 38 of 40 cases, we identified 3 (7.9%) of 38 transplants to be from a seropositive donor to a seronegative recipient. In 10 (26.3%) of 38 transplants, both the donor and recipient were seronegative, and this excluded toxoplasma as a risk. A comparison of real‐time polymerase chain reaction (PCR) and nested PCR was undertaken in combination with a range of serological assays (the Sabin‐Feldman dye test, enzyme immunoassay immunoglobulin M, and immunosorbent agglutination assay immunoglobulin M). Ethylene diamine tetraacetic acid blood samples from 3 of the 30 recipients at risk from toxoplasma were found positive by PCR, but only 1 of these was found positive in both assays. Among the 3 PCR‐positive patients, immunoglobulin M and immunoglobulin G antibody levels increased in only 1 patient. Correlations between symptoms, laboratory findings, and clinical management (use of anti‐toxoplasma therapy) are presented. Our findings suggest that toxoplasma presents a significant risk to our liver transplant population and that PCR is a helpful addition in identifying active infections and hence in informing clinical management decisions. Liver Transpl 14:1526–1532, 2008. © 2008 AASLD.Keywords
Funding Information
- Ege University Rectorate of the Scientific Research Projects Branch Directorate of Turkey (2005-TIP032)
This publication has 27 references indexed in Scilit:
- Donor‐transmitted toxoplasmosis in liver transplant recipients: a case report and literature reviewTransplant Infectious Disease, 2007
- Acute infection of Toxoplasma gondii and cytomegalovirus reactivation in a pediatric patient receiving liver transplantTransplant Infectious Disease, 2006
- ToxoplasmosisThe Lancet, 2004
- Disseminated Toxoplasmosis, Resulting from Infection of Allograft, after Orthotopic Liver Transplantation: Usefulness of Quantitative PCRJournal of Clinical Microbiology, 2002
- Disseminated toxoplasmosis after bone marrow transplantation: report of 9 casesTransplant Infectious Disease, 2001
- Toxoplasmosis after hematopoietic stem transplantation. Report of a 5-year survey from the Infectious Diseases Working Party of the European Group for Blood and Marrow TransplantationBone Marrow Transplantation, 2000
- Disseminated Toxoplasmosis after Liver TransplantationClinical Infectious Diseases, 1999
- Disseminated Toxoplasmosis After Liver Transplantation: Case Report and ReviewClinical Infectious Diseases, 1998
- Disseminated toxoplasmosis in marrow recipients: a report of three cases and a review of the literatureBone Marrow Transplantation, 1997
- Viral and toxoplasma gondii infections in children after liver transplantation.Journal of Clinical Pathology, 1990